These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8944371)

  • 1. Changes in blood rheology caused by Crohn's disease.
    Novacek G; Vogelsang H; Genser D; Moser G; Gangl A; Ehringer H; Koppensteiner R
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1089-93. PubMed ID: 8944371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of activated blood coagulation in Crohn's disease.
    Novacek G; Kapiotis S; Moser G; Speiser W; Gangl A; Vogelsang H
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):963-7. PubMed ID: 9391785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma viscosity in inflammatory bowel disease.
    Lobo AJ; Jones SC; Juby LD; Axon AT
    J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood rheology in deep venous thrombosis--relation to persistent and transient risk factors.
    Alt E; Banyai S; Banyai M; Koppensteiner R
    Thromb Res; 2002 Aug; 107(3-4):101-7. PubMed ID: 12431474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological events following laparoscopic and conventional laparotomy.
    Beilin B; Mayburd E; Yardeni IZ; Bessler H
    Clin Hemorheol Microcirc; 2005; 32(2):151-7. PubMed ID: 15764823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorrheological modifications during normal pregnancy].
    Huisman A
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):143-7. PubMed ID: 1767164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary neopterin is a valuable tool in monitoring Crohn's disease activity.
    Nancey S; Perret-Liaudet A; Moussata D; Graber I; Boschetti G; Renaud B; Kaiserlian D; Reimund JM; Flourié B
    Inflamm Bowel Dis; 2008 Nov; 14(11):1548-54. PubMed ID: 18521928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation in pediatric patients with Crohn's disease.
    Bernhard H; Deutschmann A; Leschnik B; Schweintzger S; Novak M; Hauer A; Muntean W
    Inflamm Bowel Dis; 2011 Nov; 17(11):2333-9. PubMed ID: 21287673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral mucosa lesions in patients with active Crohn’s disease - a prospective study.
    Szczeklik K; Pytko-Polończyk J; Cibor D; Owczarek D; Mach T
    Przegl Lek; 2017; 74(2):57-61. PubMed ID: 29694006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MONITORING OF HEMORHEOLOGICAL PARAMETERS IN PATIENTS WITH ATRIAL FIBRILLATION (INITIAL DATA).
    Gotsadze M; Narsia N; Momtselidze N; Mantskava M
    Georgian Med News; 2019 May; (290):59-63. PubMed ID: 31322516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level.
    Denis MA; Reenaers C; Fontaine F; Belaïche J; Louis E
    Inflamm Bowel Dis; 2007 Sep; 13(9):1100-5. PubMed ID: 17508418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT findings and clinical activity in Crohn's disease.
    Minordi LM; Vecchioli A; Guidi L; Poloni G; Fedeli G; Bonomo L
    Clin Imaging; 2009; 33(2):123-9. PubMed ID: 19237055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
    Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
    Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment.
    Jay RH; Rampling MW; Betteridge DJ
    Atherosclerosis; 1990 Dec; 85(2-3):249-56. PubMed ID: 2129320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study.
    Byrne MF; Farrell MA; Abass S; Fitzgerald A; Varghese JC; Thornton F; Murray FE; Lee MJ
    Clin Radiol; 2001 Dec; 56(12):973-8. PubMed ID: 11795926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plasma concentrations of selected antioxidant parameters in patients with active Crohn's disease.
    Szczeklik K; Krzyściak W; Cibor D; Kozioł K; Pocztar H; Pytko-Polończyk J; Mach T; Owczarek D
    Folia Med Cracov; 2018; 58(2):119-130. PubMed ID: 30467439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.